Pfizer Inc (PFE) Stock Price, Quote & News

Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands;...

Industry: Drug Manufacturers - General

Sector: Healthcare

Phone: 212 733 2323

Website: www.pfizer.com

Address:

66 Hudson Boulevard East, New York, United States

Samishere May. 28 at 5:28 AM

$PFE

0 · Reply

NEWBIGTECH May. 28 at 1:18 AM

$ESPR There are still over 9000 people still watching this stock. 9000. Somebody should know something. Where are we on the proxy, and th vote? What if $PFE Pfizer awakes from their dirt nap and makes a $5. Pps Offer. Do we vote on that?

0 · Reply

charleed138 May. 28 at 12:39 AM

$PFE this floor is strong since a whole year. people know whats going on. soon going to the sky at least half of what happened during covid.

0 · Reply

longshort168 May. 27 at 10:58 PM

$NVAX A 5-10B$ company $NVAX traded at discounted at 1.7B. $PFE

0 · Reply

Mike22332233 May. 27 at 9:52 PM

$SLS From here, $SLS could return an additional 1,650%-2,650% ... the single best asymmetrical investment I've seen in my 40+ years of investing !!! ... the opening BO Offer will be placed at about $140-$160 ... After, a 3 way Bidding War --between $MRK, $PFE, and $ABBV -- the FINAL BO PRICE will be reached at $222 in Q4 of 2026 !!! ... This is the largest position in an almost $1.4 mil portfolio … Again, this is the single best asymmetrical investment I have found in over 40 years of investing !!!! ... The play here is simple …. Buy as much as you can after doing your DD … HOLD until BO (ignore everything from now till BO) !!!! … AND after first offer is made … Look for a bidding war !!!!! … Best of luck to all !!! … And, remember to PLEASE always give back something to medical research ... If you agree ...... LIKE & FOLLOW me 👉 @Mike22332233 for all latest info and DD -- and maybe find THE NEXT SLS !!!

3 · Reply

peloswing May. 27 at 8:46 PM

The odds of a confirmed case of Ebola in the US by the end of June have spiked recently, rising 26%, to a 37% chance 🦠 Keep an eye on names like $MRNA $NVAX $BNTX $PFE in coming weeks, just in case 👀

2 · Reply

WinOrLearnCapital May. 27 at 7:56 PM

$PFE the dynamite lid is about to blow

0 · Reply

pasuny May. 27 at 7:48 PM

$PFE For God's sake fire the CEO!!! I'm begging you!!!!!

0 · Reply

Micheal_Pothead May. 27 at 7:44 PM

$PFE just another flawless walk down

0 · Reply

JBS_84 May. 27 at 7:42 PM

$PFE probably wants 26.08 before continuing

1 · Reply

Moderately bullish activity in Pfizer with shares up 1.99%

May 27, 2026, 10:00 AM EDT - 18 hours ago

Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference

2026-05-20T17:00:11.000Z - 7 days ago

Moderately bullish activity in Pfizer with shares up 0.41%

May 20, 2026, 9:00 AM EDT - 7 days ago

Sarah Cannon Research Institute Announces Strategic Oncology Research Collaboration with Pfizer

2026-05-20T09:30:10.000Z - 7 days ago

Pfizer announces pneumococcal conjugate vaccine candidate data

May 20, 2026, 5:08 AM EDT - 7 days ago

Pfizer's pneumococcal shot shows stronger immune response in mid-stage trial

May 20, 2026, 5:05 AM EDT - 7 days ago

Pfizer Advances Pivotal Pediatric Pneumococcal Vaccine Program Following Strong Positive Phase 2 Results

2026-05-18T17:01:06.000Z - 9 days ago

PFE, NVO, LLY: Pharma Stocks Drop as TrumpRx Set for ‘Dramatic Expansion’

AZN LLY NVO SNY

May 18, 2026, 8:00 AM EDT - 9 days ago

Astellas to Present Data on Long-Term Outcomes and Clinical Use of Its Portfolio Across Disease Stages at ASCO 2026

May 14, 2026, 2:22 PM EDT - 13 days ago

Quest Diagnostics, Altria, and 12 More Stocks That Are Coming Back to Life After a Rough Patch

DGX MO CL

2026-05-14T17:29:38.000Z - 13 days ago

Pfizer price target raised to $26 from $25 at Wolfe Research

2026-05-13T19:23:39.000Z - 14 days ago

Mixed options sentiment in Pfizer with shares up 0.48%

2026-05-13T19:22:15.000Z - 14 days ago

Arvinas price target raised to $16 from $14 at BofA

ARVN RIGL

2026-05-13T11:10:14.000Z - 14 days ago

Pfizer says EC grants marketing approval to expand indication for Hympavzi

May 13, 2026, 6:45 AM EDT - 14 days ago

European Commission Approves Pfizer's HYMPAVZI for the Treatment of Adults and Adolescents with Hemophilia A or B With Inhibitors

2026-05-13T07:12:25.000Z - 15 days ago

Pfizer (PFE) Delivered a Solid Q1. The Patent Cliff Keeps Me Bearish

LLY NVO

2026-05-12T17:45:03.000Z - 15 days ago

H.C. Wainwright says Pfizer handing off Veppanu to Rigel ‘makes strategic sense’

ARVN RIGL

2026-05-12T16:35:26.000Z - 15 days ago

Arvinas, Pfizer enter license pact with Rigel Pharmaceuticals for Veppanu

ARVN RIGL

May 12, 2026, 8:00 AM EDT - 15 days ago

Rigel strikes licensing deal for Pfizer and Arvinas' breast cancer drug

ARVN RIGL

May 12, 2026, 7:00 AM EDT - 15 days ago

Arvinas and Pfizer Enter into a Transaction with Rigel Pharmaceuticals for the Exclusive Global Rights of VEPPANU (vepdegestrant)

ARVN

May 5, 2026, 4:09 PM EDT - 22 days ago

Pfizer CEO on Drug Pipeline, Trump's Pick to Lead CDC

May 5, 2026, 4:02 PM EDT - 22 days ago

Pfizer CEO on AI-designed molecule, and race to use new tech

May 5, 2026, 11:30 AM EDT - 22 days ago

3 Dividend Stocks for May 2026

SYY WSO

May 5, 2026, 10:00 AM EDT - 22 days ago

Pfizer Earnings Call Transcript: Q1 2026

May 5, 2026, 10:00 AM EDT - 22 days ago

Pfizer Earnings release: Q1 2026

May 5, 2026, 10:00 AM EDT - 22 days ago

Pfizer Quarterly report: Q1 2026

May 5, 2026, 10:00 AM EDT - 22 days ago

Pfizer Slides: Q1 2026

May 5, 2026, 8:35 AM EDT - 22 days ago

Pfizer Posts Better-Than-Expected Revenue, Profit

May 5, 2026, 7:23 AM EDT - 22 days ago

Pfizer Revenue Rises But Profit Falls Amid Boosted R&D Spending

May 5, 2026, 7:06 AM EDT - 22 days ago

Pfizer Stock Edges Higher as Earnings and Revenue Beat Estimates

May 5, 2026, 7:05 AM EDT - 22 days ago

Why selling these 3 dividend stocks could be a mistake

EPD UPS

May 5, 2026, 6:55 AM EDT - 22 days ago

Pfizer tops Wall Street estimates, reaffirms outlook as newer products show growth

May 5, 2026, 6:51 AM EDT - 22 days ago

Pfizer beats first-quarter profit estimates on strong demand for blood thinner Eliquis

May 5, 2026, 6:45 AM EDT - 22 days ago

Pfizer Reports Strong First-Quarter Results And Reaffirms 2026 Guidance

May 1, 2026, 12:37 PM EDT - 26 days ago

US FDA approves Pfizer, Arvinas' breast cancer drug

ARVN

Apr 29, 2026, 7:42 AM EDT - 4 weeks ago

Pfizer's blood cancer drug meets main goal in late-stage trial

$Pfizer's ELREXFIO Significantly Improves Progression-Free Survival for Double-Class Exposed Patients with Relapsed or Refractory Multiple Myeloma$

Apr 29, 2026, 6:45 AM EDT - 4 weeks ago

Pfizer's ELREXFIO Significantly Improves Progression-Free Survival for Double-Class Exposed Patients with Relapsed or Refractory Multiple Myeloma

Apr 28, 2026, 10:41 AM EDT - 4 weeks ago

Pfizer secures deals to keep heart drug free of generic rivals until 2031

Apr 28, 2026, 10:17 AM EDT - 4 weeks ago

Pfizer Reaches Three Settlement Agreements for VYNDAMAX

Apr 24, 2026, 8:36 AM EDT - 4 weeks ago

Bristol Myers, Pfizer to offer blockbuster blood thinner through Mark Cuban's online pharmacy

BMY

Apr 23, 2026, 9:00 AM EDT - 4 weeks ago

Pfizer Transcript: AGM 2026

Apr 22, 2026, 4:45 PM EDT - 5 weeks ago

Pfizer Declares Second-Quarter 2026 Dividend

Apr 22, 2026, 5:18 AM EDT - 5 weeks ago

Pfizer GLP-1 weight loss drug available for pre-order in China

Apr 21, 2026, 11:51 AM EDT - 5 weeks ago

Pfizer Showcases Oncology Innovation and Next-Generation Pipeline at ASCO 2026

Apr 20, 2026, 3:05 PM EDT - 5 weeks ago

Pfizer's Strategy and Innovation Officer Andrew Baum to leave drugmaker, analyst note says

Apr 20, 2026, 6:45 AM EDT - 5 weeks ago

U.S. FDA Grants Priority Review to sBLA for PADCEV™ + Keytruda® as Perioperative Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility

Apr 16, 2026, 1:01 PM EDT - 5 weeks ago

The Big 3: PFE, V, SYF

SYF V

Apr 10, 2026, 11:00 PM EDT - 6 weeks ago

Big Pharma Is Turning to China for the Newest Drug Ideas

Apr 9, 2026, 10:00 AM EDT - 6 weeks ago

Pfizer Invites Shareholders to View and Listen to Webcast of April 23 Virtual 2026 Annual Meeting of Shareholders

Apr 2, 2026, 11:14 AM EDT - 7 weeks ago

Trump administration prepares up to 100% pharmaceutical tariffs on some imported drugs

NVO LLY

Apr 1, 2026, 11:39 AM EDT - 2 months ago

Exclusive: Pfizer, BioNTech halt US COVID vaccine study after recruitment struggles

BNTX

Apr 1, 2026, 10:13 AM EDT - 2 months ago

Belgian court orders Poland, Romania to buy $2.2 billion of Pfizer COVID vaccines

Mar 30, 2026, 10:44 AM EDT - 2 months ago

Pharma Offers Defensive Plays in an Uncertain Market. Charts Say Buy These 2 Stocks.

GSK LLY NVO PPH

Mar 24, 2026, 10:00 AM EDT - 2 months ago

Pfizer Invites Public to View and Listen to Webcast of May 5 Conference Call with Analysts

Mar 23, 2026, 12:46 PM EDT - 2 months ago

An experimental Lyme disease vaccine from Pfizer and Valneva was effective at preventing the tick-borne disease in a new clinical trial but the findings aren't conclusive

VALN

Mar 23, 2026, 9:36 AM EDT - 2 months ago

Pfizer to seek FDA approval for Lyme disease vaccine candidate despite trial miss

VALN

Mar 23, 2026, 7:07 AM EDT - 2 months ago

Pfizer and French partner to seek approval for Lyme disease vaccine after late-stage trial

VALN

Mar 23, 2026, 7:02 AM EDT - 2 months ago

Pfizer, Valneva Report Strong Efficacy Data From Lyme Vaccine Trial

VALN

Mar 23, 2026, 6:47 AM EDT - 2 months ago

Pfizer-Valneva Lyme disease shot shows more than 70% efficacy in late-stage trial

VALN

Mar 23, 2026, 6:45 AM EDT - 2 months ago

Pfizer and Valneva Announce Lyme Disease Vaccine Candidate Demonstrates Strong Efficacy in Phase 3 VALOR Trial

VALN

Mar 22, 2026, 9:45 AM EDT - 2 months ago

5 ‘Healthy' Dividends Paying Up To 14.1%

ARE BME DOC HQH

Mar 20, 2026, 4:30 PM EDT - 2 months ago

Pfizer Recommends Shareholders Reject the Mini-Tender Offer by Tutanota LLC

Mar 19, 2026, 6:45 AM EDT - 2 months ago

TALZENNA Plus XTANDI Significantly Improves Radiographic Progression-Free Survival in Metastatic Prostate Cancer

Mar 18, 2026, 2:23 PM EDT - 2 months ago

TrumpRx lists many medicines at prices higher than paid in UK

ABBV AMGN AZN BMY GILD GSK JNJ

Mar 17, 2026, 7:49 AM EDT - 2 months ago

Pfizer says experimental breast cancer drug cuts risk of disease worsening in mid-stage trial

Mar 17, 2026, 6:45 AM EDT - 2 months ago

Pfizer Announces Positive Topline Phase 2 Results for Next-Generation CDK4 Inhibitor, Atirmociclib, in Second-Line Metastatic Breast Cancer

Samishere May. 28 at 5:28 AM

$PFE

0 · Reply

NEWBIGTECH May. 28 at 1:18 AM

0 · Reply

charleed138 May. 28 at 12:39 AM

$PFE this floor is strong since a whole year. people know whats going on. soon going to the sky at least half of what happened during covid.

0 · Reply

longshort168 May. 27 at 10:58 PM

$NVAX A 5-10B$ company $NVAX traded at discounted at 1.7B. $PFE

0 · Reply

Mike22332233 May. 27 at 9:52 PM

3 · Reply

peloswing May. 27 at 8:46 PM

2 · Reply

WinOrLearnCapital May. 27 at 7:56 PM

$PFE the dynamite lid is about to blow

0 · Reply

pasuny May. 27 at 7:48 PM

$PFE For God's sake fire the CEO!!! I'm begging you!!!!!

0 · Reply

Micheal_Pothead May. 27 at 7:44 PM

$PFE just another flawless walk down

0 · Reply

JBS_84 May. 27 at 7:42 PM

$PFE probably wants 26.08 before continuing

1 · Reply

Mrdrifter May. 27 at 6:50 PM

$PFE game on

1 · Reply

funnymoney90210 May. 27 at 6:50 PM

$PFE

0 · Reply

Typecheck May. 27 at 6:42 PM

$PFE never trust a Pfizer pop. Keep selling covered calls my friends.

2 · Reply

Catalystinvestor May. 27 at 6:38 PM

$LLY making a move to buy three vaccine makers. Bodes well for $ABUS as it owns ( with Genevant) the delivery technology used for mRNA vaccines. If LLY buy abus, would $PFE make a counter offer as they have to pay for Abus’s intellectual property they used for COVID vaccines anyway. https://www.cnbc.com/2026/05/27/eli-lilly-makes-a-new-push-into-vaccines-heres-what-to-know.html

0 · Reply

Micheal_Pothead May. 27 at 6:31 PM

$PFE holy shit it never changes

0 · Reply

pasuny May. 27 at 6:29 PM

$PFE Miserable stupid dirty garbage

0 · Reply

reyofhope May. 27 at 6:27 PM

$PFE I'm holding this long term.

0 · Reply

pasuny May. 27 at 5:31 PM

$PFE 씨발 개잡주 진짜 징하다 징해. 씨발 좃 같은CEO 좀 제발 잘라라... 어떻게 씨발 5년을 주식이 똥을 싸고 빌빌 거릴 수가 있냐... 씨발 닭대가리를 앉혀놔도 회사가 최소한 10%는 성장하겠다. 진짜 개좃같은 CEO 하나 때문에 원탑 회사거 개 쓰레기 잡주로 떨어지네...

1 · Reply

pasuny May. 27 at 5:27 PM

$PFE Stupid fucking garbage. Disgusting.

0 · Reply

Mike22332233 May. 27 at 5:12 PM

$SLS I have been one of the very few -- if not the only one -- that has CONSISTENTLY been saying: ... When the 80th event occurs, you will find that all 63 out of 63 BAT patients have passed ... And that 46 of the 63 GPS patients still live ... (that is my most logical conclusion based on all the data out over time) ... And, the HR value will be GROUND BREAKING and a new SoC !!!! .... And, BO will involve a bidding war between 2 -- and maybe even 3 -- of the following: $MRK, $PFE, and &ABBV !!! ... If you agree ...... LIKE & FOLLOW me 👉 @Mike22332233 for all latest info and DD

2 · Reply

Micheal_Pothead May. 27 at 4:50 PM

$PFE can’t stand the way this stock moves

0 · Reply

nimii May. 27 at 4:46 PM

$PFE ebola 🤲😱🍡

0 · Reply

Market Cap	147.33B
Revenue (ttm)	62.58B
Net Income (ttm)	7.77B
EPS (ttm)	N/A
PE Ratio	8.46
Forward PE	8.67
Profit Margin	12.42%
Debt to Equity Ratio	0.71

Volume	39,024,600
Avg Vol	36,973,660
Day's Range	N/A - N/A
Shares Out	5.70B
Stochastic %K	76%
Beta	0.35
Analysts	Sell
Price Target	$29.28